Latest Healthcare Research Reports

Subcutaneous Immunoglobulin (SCIG) Market Report 2024: Market Size, Drivers, And Trends

Global Subcutaneous Immunoglobulin (SCIG) Market

Written by

The Business Research Company

in

The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

Current Market Overview

  • The subcutaneous immunoglobulin market is expanding swiftly.
  • 2023 Market Size: $11.19 billion.
  • 2024 Market Size: Expected to reach $12.72 billion, with a CAGR of 13.7%.
  • Growth Drivers:
    • Increased prevalence of immunodeficiency disorders.
    • Rise in patient preference for home-based care.
    • Enhanced therapeutic efficacy.
    • Growth in awareness and diagnosis rates.
    • Favorable reimbursement policies.

Future Market Projections

  • The market will continue to grow significantly.
  • 2028 Market Size: Expected to reach $21.38 billion, with a CAGR of 13.9%.
  • Growth Drivers:
    • Growing prevalence of neurological disorders.
    • Increasing prevalence of autoimmune diseases.
    • Rising awareness and acceptance of immunoglobulin therapy.
    • Expanding applications in neurology and dermatology.
    • Expansion of healthcare facilities.
  • Major Trends:
    • Advancements in drug delivery systems.
    • Increasing demand for home infusion therapies.
    • Developments in antibody therapy.
    • Innovations in formulations and SCIG.

View More On The Subcutaneous Immunoglobulin (SCIG) Market Report 2024 – https://www.thebusinessresearchcompany.com/report/subcutaneous-immunoglobulin-scig-global-market-report

Impact of Secondary Immunodeficiency Diseases

Growing Prevalence and Market Impact

  • Secondary Immunodeficiency Diseases: Conditions caused by external factors like aging, immunosuppressive treatments, and environmental toxins.
  • Impact: These diseases necessitate subcutaneous immunoglobulin therapy, which strengthens the immune system and prevents infections.
  • Example:
    • UK Health Security Agency Report (October 2023): 3,805 new HIV diagnoses in England in 2022, a 22% rise from the previous year.
  • Conclusion: Increased prevalence of secondary immunodeficiency diseases drives market growth.

Rising Neurological Disorders

Contribution to Market Expansion

  • Neurological Disorders: Includes conditions like Alzheimer’s, ALS, brain tumors, etc.
  • Increasing Factors: Aging populations, environmental toxins, genetic predispositions, lifestyle changes.
  • Therapeutic Benefits:
    • Modulates immune response.
    • Reduces inflammation.
    • Stabilizes neuromuscular junctions.
    • Slows disease progression and improves symptoms.
  • Example:
    • Alzheimer’s Association Report (March 2022): 6.5 million Americans aged 65 and older living with Alzheimer’s dementia, projected to reach 13.8 million by 2060.
  • Conclusion: Rising neurological disorders contribute to market growth.

Major Players in the Subcutaneous Immunoglobulin Market

Key Companies

  • Major Companies:
    • Pfizer Inc.
    • Johnson & Johnson.
    • Prothena Corporation plc.
    • GlaxoSmithKline plc.
    • Takeda Pharmaceutical Company Limited.
    • Amgen Inc.
    • Baxter International Inc.
    • CSL Behring.
    • Lonza Group.
    • Grifols S.A.
    • Octapharma AG.
    • Dr. Reddy’s Laboratories.
    • Intas Pharmaceutical Ltd.
    • Emergent BioSolutions Inc.
    • Bharat Serums and Vaccines Limited (BSV).
    • Kamada Pharmaceuticals.
    • CinnaGen Co.
    • Shire plc.

Advancements in SCIG Therapy for Primary Immunodeficiency Diseases

Innovative Products and Treatments

  • Subcutaneous Human-klhw: A unique formulation for treating primary immunodeficiency diseases.
  • Example:
    • Grifols S.A. (March 2022): Launched XEMBIFY 20% SCIG, designed for primary immunodeficiency.
    • Features:
      • Ready-to-use formulation.
      • Simplifies treatment process.
      • Increases patient convenience.
      • Stable at room temperature for up to 24 months.

Market Segmentation

Product Types and Applications

  • By Product Type:
    • Immunoglobulin A (IgA).
    • Immunoglobulin G (IgG).
    • Immunoglobulin M (IgM).
  • By Application:
    • Primary Immunodeficiency Disorders.
    • Autoimmune Diseases.
    • Neurological Disorders.
    • Other Applications.
  • By End-Use:
    • Clinics.
    • Hospitals.
    • Homecare.
    • Other End-Uses.

Regional Insights

Geographic Market Dynamics

  • Largest Region (2023): North America.
  • Fastest-Growing Region (Forecast Period): Asia-Pacific.

The subcutaneous immunoglobulin market is set for continued growth, driven by increasing prevalence of various disorders and advancements in therapy and drug delivery systems.

Request A Sample Of The Global Subcutaneous Immunoglobulin (SCIG) Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=15935&type=smp

More posts